| Literature DB >> 32707994 |
Abstract
Fatty acid esters of hydroxy fatty acids (FAHFAs) constitute a class of recently identified novel lipids exhibiting anti-diabetic and anti-inflammatory effects. Due to their high biological significance, a tremendous effort has been devoted to the development of analytical methods for the detection and quantitation of FAHFAs during the last five years. The analysis of FAHFAs is very challenging due to the great number of possible regio-isomers arising from the great number of possible combinations of FAs with HFAs, and the low abundancies of FAHFAs in biological samples. The aim of this review article is to summarize all the cutting-edge analytical methodologies for the determination of FAHFAs in biological samples, plant tissues and food matrices, with emphasis on extraction and analysis steps. All the analytical methodologies rely on the use of liquid chromatography-mass spectrometry (LC-MS), providing high sensitivity due to the MS detection. Powerful and robust analytical methodologies may highly contribute in studying FAHFAs levels under various biomedical conditions, and facilitate our understanding of the role of these lipid species in physiological and pathological conditions.Entities:
Keywords: anti-diabetic; anti-inflammatory; fatty acid esters of hydroxy fatty acids (FAHFAs); lipidomics; liquid chromatography–mass spectrometry (LC-MS)
Mesh:
Substances:
Year: 2020 PMID: 32707994 PMCID: PMC7463945 DOI: 10.3390/biom10081092
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1General structure of fatty acid esters of hydroxy fatty acids (FAHFAs).
Figure 2Representative structures of FAHFAs.
Figure 3Fragmentation pathway of 9-PAHSA.
Figure 4Fragmentation pathway of 13-DHAHLA.
Figure 52-Dimethylaminoethylamine (DMED) derivatization reaction (A) and fragmentation of DMED-labeled 9-PAHSA (B).
Figure 6N-(4-Aminomethylphenyl) pyridinium (AMPP) derivatization reaction (A) and representative structure of the most abundant ion (B).
Overview of the analytical methodologies for the study of FAHFAs.
| Analytical Technique | Derivatization | Instrumental Analysis | Column/Mobile Phase | Sample | Sample Preparation— | Ref. |
|---|---|---|---|---|---|---|
| LC-MS/MS, | No | Agilent 6410 (triple quadrupole) combined with | Luna C18 column | Human or mouse serum, subcutaneous WAT, mouse perigonadal WAT, BAT and liver | Bligh–Dyer method/HyperSep silica SPE column (500 mg bed weight, 6 mL column volume, Thermo Scientific) | [ |
| LC-MS/MS, | No | QTRAP 5500/SelexION, (Sciex, Framingham, MA, USA). hybrid triple quadrupole | Kinetex C18 | Epididymal WAT, subcutaneous WAT, liver, interscapular BAT and serum | Citric acid buffer, methanol, dichloromethane (1:1:2)/Strata SI-1 silica SPE cartridge (50 μg silica, 70 Å, Sigma-Aldrich) | [ |
| LC-MS/MS, | No | Agilent 6460 (triple quadrupole) combined with | C18 Mediterranea column | Human serum | Deproteinization by addition of methanol/On-line SPE Hysphere C8 cartridges | [ |
| UHPLC-MS/MS, | DMED and | Shimadzu MS-8040 triple quadrupole combined with Shimadzu LC-30AD UPLC system (Shimadzu, Kyoto, Japan). | Acquity UPLC BEH C18 column (2.1 × 50 mm, 1.7 μm, Waters)/mobile phase (A) formic acid in ACN/water (0.1%, 6/4, | Rat WAT, lung, kidney, thymus, liver and heart tissues. Human serum from healthy individuals and breast cancer patients | ACN containing 0.1% NH3.H2O/Strong anion exchange solid phase extraction SAX SPE-cartridge (1 mL, 50 mg, Weltech Co) | [ |
| UPLC-MS/MS, | No | QTRAP 5500/SelexION, hybrid triple quadrupole | Kinetex C18 | Murine tissues and human breast milk | Citric acid buffer, methanol, dichloromethane (1:1:2)/HyperSep SPE column (500 mg/10 mL, 40–60 μm, 70 Å, Thermo) | [ |
| UPLC-MS/MS, | No | Agilent |
Acquity BEH C18 column | WAT from hamsters | Methyl | [ |
| LC-MS, | No | TSQ Quantiva LC-MS instrument (Thermo Fisher | Acquity UPLC BEH C18 column (1.7 μm, 2.1 mm × 100 mm, Waters)/isocratic 93:7 methanol/water with 5 mM ammonium acetate and 0.03% ammonium hydroxide ( | Perigonadal WAT and human plasma | Phospate-buffered saline (PBS), methanol, chloroform (1:1:2)/Strata SI-1 silica SPE cartridge (500 mg silica, 3 mL, Phenomenex) | [ |
| UHPLC-MS/MS, | DMED | Shimadzu MS-8045 mass spectrometer combined with a Shimadzu LC-30AD HPLC system | Acquity UPLC BEH C18 column (2.1 mm × 50 mm, 1.7 μm, Waters)/Formic acid in water (0.1%, | Rice and | Bligh-Dyer method/Strong anion exchange solid phase extraction (SAX SPE) cartridge (3 mL, 200 mg, Weltech Co) | [ |
| LC-MS/MS, | No | qTOF Synapt G2-Si mass spectrometer (Waters, Milford, MA, USA) coupled to Waters nanoAcquity UPLC | XTerra MSC18 3.5 μm NanoEase column (75 μm × 150 mm, Waters)/Isocratic elution 93:7 methanol:water phase buffer consisted of 5 mmol/L ammonium acetate and 0.01% ammonium hydroxide; flow rate: 0.7 μL/min for 30 min |
Oat (whole grain, coarse flakes and fine flakes), apple, | Citric acid buffer, methanol, chloroform (1:1.5:3)/HyperSep silica cartridge | [ |
| MS, | AMPP | TSQ Quantiva triple quadrupole mass spectrometer (Thermo Fisher Scientific) equipped with an automated nanospray | - | Liver and WAT from homozygous diabetic ( | HyperSep silica SPE cartridge (200 mg, 3 mL, Thermo | [ |
| LC-HRMS/MS, | DMED | LTQ Orbitrap Elite mass spectrometer (Thermo Fisher Scientific) combined with UltiMate 3000 UHPLC System (Thermo Fisher Scientific). | Acquity UPLC BEH C18 column (2.1 mm × 50 mm, 1.7 μm, Waters)/A ACN/water (6/4, |
| Methanol, chloroform, water (1:2:1)/Strong anion exchange solid phase extraction SAX-SPE cartridge (200 mg, 3 mL, Weltech Co) | [ |
Multiple reaction monitoring (MRM) transition list.
| Analyte | Quantitative Transition ( | Qualitative Ions ( | Ref. |
|---|---|---|---|
| PAHSA | 537 → 255 | 299, 281 | [ |
| SAHSA | 565 → 283 | 299, 281 | [ |
| OAHSA | 563 → 281 | 299, 281 | [ |
| POHSA | 535 → 253 | 299, 281 | [ |
| DHAHLA | 605 → 327 | 295, 277 | [ |
| DHAHDHA | 653 → 327 | 343, 325 | [ |
Contents of particular PAHSAs in biological and food samples [2,6].
| Source | 5-PAHSA | 9-PAHSA | 13/12-PAHSA | Total PAHSA |
|---|---|---|---|---|
| Serum | 0.2–0.5 * | 1–4 * | 2–3 * | 7–10 * |
| WAT | 40 | 100 | 25 | 150–200 |
| BAT | 180 | 120 | 30 | 250–300 |
| Liver | 0 | 20 | 10 | 30 |
| Kidney | 5 | 20 | 2 | - |
| Pancreas | 0 | 5 | 4 | - |
| Apple | 0.1 | 0.4 | 0.8 | - |
| Broccoli | - | 1.7 | 1.3 | - |
| Beef | - | 4 | 6 | - |
| Chicken | 0.25 | 1.2 | 2 | - |
| Egg yolk | - | 4 | 7 | - |
| Egg white | - | 0.3 | 0.5 | - |
* pmol/mL.
Contents of FAHFAs in the WAT of rats [22].
| FAHFA | Rat WAT |
|---|---|
| 13-PAHSA | 84.6 |
| 12-PAHSA | 22.1 |
| 9-PAHSA | 89.8 |
| 9-OAHSA | 13.9 |
| 13-SAHSA | 81.9 |
| 12-SAHSA | 132.1 |
| 9-SAHSA | 51.7 |
Contents of FAHFAs in foods [20].
| Source | FAHFAs |
|---|---|
| Whole grain oat | 3.20 |
| Clementine | 2.51 |
| Garlic | 2.43 |
| Pineapple | 2.16 |
| Strawberries | 1.59 |
| Mango | 1.51 |
| Carrot | 1.40 |
| Parsley root | 1.14 |